Literature DB >> 6747609

Detection and characterization of hepatitis B virus DNA in serum of HBe antigen-negative HBsAg carriers.

R Tur-Kaspa, E Keshet, M Eliakim, D Shouval.   

Abstract

Sera from 153 Israeli patients in various stages of hepatitis B virus (HBV) infection with undetectable hepatitis Be antigen (HBeAg) were studied for the presence of HBV DNA in the serum by molecular hybridization. HBV DNA was detected in 10 patients: 3 with acute hepatitis, 4 asymptomatic hepatitis B surface antigen (HBsAg) carriers, 1 with chronic active hepatitis, 1 with cirrhosis, and 1 with mixed cryoglobulinemia. HBV DNA was detected in 7 of 10 HBeAg-positive control samples tested. Hybridization analysis was used for quantitative comparison of HBV DNA levels in serum. HBV DNA levels, found in HBeAg-negative patients sometimes exceeded the levels found in HBeAg-positive patients. Restriction enzyme analysis of serum HBV DNA from four HBeAg-negative samples gave undistinguishable digestion patterns as compared to 3 HBeAg-positive samples. However, heterogeneity in HBV DNA restriction fragments was detected among HBV genomes in sera of HBeAg-positive samples. These data demonstrate that HBV DNA may be present in the serum at various stages of HBV infection, regardless of HBeAg detection. Failure to detect HBeAg in these patients does not necessarily reflect low serum levels of viral particles, or the occurrence of HBV genome variants.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6747609     DOI: 10.1002/jmv.1890140104

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.

Authors:  G M Ginsberg; D Shouval
Journal:  J Epidemiol Community Health       Date:  1992-12       Impact factor: 3.710

2.  Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.

Authors:  M R Brunetto; M M Giarin; F Oliveri; E Chiaberge; M Baldi; A Alfarano; A Serra; G Saracco; G Verme; H Will
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  HBV-DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy.

Authors:  M Rapicetta; V di Nardo; C Rozera; G Marinucci; D Francisci; B Sarrecchia; C Ricci; F Albertoni
Journal:  Epidemiol Infect       Date:  1990-06       Impact factor: 2.451

4.  Hepatitis B virus replication in patients with chronic liver diseases.

Authors:  B M Gandhi; M Irshad; S K Acharya; Y K Joshi; B N Tandon
Journal:  Gastroenterol Jpn       Date:  1990-04

5.  Assay of hepatitis B virus genome titers in sera of infected subjects.

Authors:  E Zyzik; W H Gerlich; A Uy; H Köchel; R Thomssen
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

6.  Incidence of hepatitis B virus DNA and DNA-polymerase in sera of Italian asymptomatic carriers with the serological markers of HBV.

Authors:  G Carloni; C Delfini; S Colloca; E Alfani; G Taliani; C De Bac
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

7.  Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay.

Authors:  S Kaneko; R H Miller; S M Feinstone; M Unoura; K Kobayashi; N Hattori; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

8.  Hepatitis B virus DNA and e antigen in serum from blood donors in the United Kingdom positive for hepatitis B surface antigen.

Authors:  T J Harrison; V Bal; E G Wheeler; T J Meacock; J F Harrison; A J Zuckerman
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02

9.  HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B.

Authors:  Yael Gozlan; Daniella Aaron; Yana Davidov; Maria Likhter; Gil Ben Yakov; Oranit Cohen-Ezra; Orit Picard; Oran Erster; Ella Mendelson; Ziv Ben-Ari; Fadi Abu Baker; Orna Mor
Journal:  Viruses       Date:  2022-03-11       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.